Andrew J. Schwab

Insider Reports History

Entity
Individual
Location
C/O 5 Am Ventures, 501 2 Nd Street, Suite 350, San Francisco, California
Signature
/s/ Andrew J. Schwab
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Schwab:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 8.39M $83.9M $10.00 Mar 13, 2024 By 5AM Ventures VII, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 1.72M $17.2M $10.00 Mar 13, 2024 By 5AM Ventures II, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 67.8K $678K $10.00 Mar 13, 2024 By 5AM Co-Investors II, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 14.6M Dec 3, 2021 by 5AM Ventures IV, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 3.37M Dec 3, 2021 by 5AM Opportunities I, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 610K Dec 3, 2021 by 5AM Co-Investors IV, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 35K Feb 29, 2024 Direct
Enliven Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 27.6K Feb 23, 2023 Direct

Insider Reports Filed by Andrew J. Schwab

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SKYE Skye Bioscience, Inc. Mar 13, 2024 1 $4.5M 4 Mar 15, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 Director
SKYE Skye Bioscience, Inc. Jan 31, 2024 1 $12M 4 Feb 2, 2024 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Nov 6, 2023 1 $0 4 Nov 6, 2023 Director
SKYE Skye Bioscience, Inc. Aug 25, 2023 1 $0 4 Aug 29, 2023 Director
SKYE Skye Bioscience, Inc. Aug 18, 2023 6 $8.78M 4 Aug 22, 2023 Director, 10%+ Owner
SKYE Skye Bioscience, Inc. Aug 18, 2023 0 $0 3 Aug 22, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 4 $2M 4 Dec 7, 2021 Director, 10%+ Owner
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Director, 10%+ Owner